Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Operating Leases (2019 - 2025)

Historic Operating Leases for Gyre Therapeutics (GYRE) over the last 7 years, with Q3 2025 value amounting to $539000.0.

  • Gyre Therapeutics' Operating Leases fell 5104.45% to $539000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $539000.0, marking a year-over-year decrease of 5104.45%. This contributed to the annual value of $885000.0 for FY2024, which is 34472.36% up from last year.
  • Per Gyre Therapeutics' latest filing, its Operating Leases stood at $539000.0 for Q3 2025, which was down 5104.45% from $771000.0 recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Operating Leases registered a high of $1.3 million during Q2 2024, and its lowest value of $121000.0 during Q4 2022.
  • For the 5-year period, Gyre Therapeutics' Operating Leases averaged around $668153.8, with its median value being $771000.0 (2025).
  • Its Operating Leases has fluctuated over the past 5 years, first crashed by 7034.31% in 2022, then skyrocketed by 34571.43% in 2025.
  • Gyre Therapeutics' Operating Leases (Quarter) stood at $408000.0 in 2021, then plummeted by 70.34% to $121000.0 in 2022, then soared by 64.46% to $199000.0 in 2023, then surged by 344.72% to $885000.0 in 2024, then tumbled by 39.1% to $539000.0 in 2025.
  • Its Operating Leases was $539000.0 in Q3 2025, compared to $771000.0 in Q2 2025 and $780000.0 in Q1 2025.